News
CYCN
3.033
+1.09%
0.033
Weekly Report: what happened at CYCN last week (0413-0417)?
Weekly Report · 2d ago
Weekly Report: what happened at CYCN last week (0406-0410)?
Weekly Report · 04/13 09:02
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 04/07 21:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 04/07 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/06 17:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 04/06 12:05
Weekly Report: what happened at CYCN last week (0330-0403)?
Weekly Report · 04/06 09:02
Deal Dispatch: McCormick, Unilever Merge, Sysco Acquires Jetro Restaurant Depot For $29 Billion, QVC Considers Bankruptcy
Benzinga · 04/03 14:35
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 04/02 12:05
Penny Stock CYCN Surged More Than 300% Yesterday. Why, And Should You Chase the Rally Here?
Barchart · 04/02 08:15
Globalstar, Exxon Mobil, Cyclerion Therapeutics, Eli Lilly And Intel: Why These 5 Stocks Are On Investors' Radars Today
Benzinga · 04/02 02:33
CYCN Stock Alert: Halper Sadeh LLC is Investigating Whether Cyclerion Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders
Barchart · 04/02 00:08
Cyclerion Therapeutics to Merge with Korsana Biosciences
TipRanks · 04/01 20:29
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/01 17:06
BUZZ-U.S. STOCKS ON THE MOVE-Intel, Tempus AI, Boeing
Reuters · 04/01 16:14
Crude Oil Down Over 1%; ISM Manufacturing PMI Rises In March
Benzinga · 04/01 16:03
Cyclerion Therapeutics Stock Soars 350% On Korsana Merger, $380 Million Financing
Benzinga · 04/01 14:53
Dow Jumps Over 200 Points; Nike Shares Tumble After Q3 Results
Benzinga · 04/01 14:33
ISM Manufacturing unexpectedly rises in March
Seeking Alpha · 04/01 14:04
BUZZ-Cyclerion soars on merger deal with Korsana
Reuters · 04/01 13:16
More
Webull provides a variety of real-time CYCN stock news. You can receive the latest news about Cyclerion Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYCN
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.